Default sorting
Show

  • KAUSKAS-100

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…

  • KAUSKAS-200

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…

  • KAUSKAS-50

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…

  • KEIKAI

    Monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over. This is only…

  • LAKCAY

    Raloxifen is indicated for the treatment and prevention of osteoporosis in postmenopausal women. A significant reduction in the incidence of vertebral, but not hip fractures…

  • LAMPAR

    Treatment of gastrointestinal symptoms (heartburn, nausea/vomiting) associated with chronic gastroesophageal reflux. This is only the preview. Please check here for the full indication.

  • LEVETRAL

    Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed…

  • LEVETRAL-750

    Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed…

  • MAGRAX

    Treatment of rheumatoid arthritis (RA), inflammation associated with acute gouty arthritis, ankylosing spondylitis in adults and adolescents 16 years of age and older. Treatment of…

  • MAGRAX-F

    Acute gouty arthritis This is only the preview. Please check here for the full indication.

  • MALAG-60

    Fexofenadine is indicated in adults and children 6 years and older for the relief of symptoms associated with seasonal allergic rhinitis. This is only the…

  • MANZURA-15

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…